Topics

Adaptive Phage gets $10M from DoD for antibacterial phage therapies

10:00 EST 8 Jan 2020 | MedCity News

The company is developing phage-based therapies designed to target specific bacteria strains, as contrasted with antibiotics, which target multiple types of bacteria.

Original Article: Adaptive Phage gets $10M from DoD for antibacterial phage therapies

NEXT ARTICLE

More From BioPortfolio on "Adaptive Phage gets $10M from DoD for antibacterial phage therapies"

Quick Search